- Home
- ACET vs FSHP Comparison
ACET vs FSHP Comparison
Compare ACET & FSHP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACET
- FSHP
- Stock Information
- Founded
- ACET 1947
- FSHP 2018
- Country
- ACET United States
- FSHP United States
- Employees
- ACET N/A
- FSHP N/A
- Industry
- ACET Biotechnology: Pharmaceutical Preparations
- FSHP
- Sector
- ACET Health Care
- FSHP
- Exchange
- ACET Nasdaq
- FSHP NYSE
- Market Cap
- ACET 75.6M
- FSHP 90.3M
- IPO Year
- ACET N/A
- FSHP 2024
- Fundamental
- Price
- ACET $0.91
- FSHP $10.17
- Analyst Decision
- ACET Strong Buy
- FSHP
- Analyst Count
- ACET 4
- FSHP 0
- Target Price
- ACET $5.67
- FSHP N/A
- AVG Volume (30 Days)
- ACET 513.3K
- FSHP 21.4K
- Earning Date
- ACET 11-06-2024
- FSHP 01-01-0001
- Dividend Yield
- ACET N/A
- FSHP N/A
- EPS Growth
- ACET N/A
- FSHP N/A
- EPS
- ACET N/A
- FSHP 0.11
- Revenue
- ACET N/A
- FSHP N/A
- Revenue This Year
- ACET N/A
- FSHP N/A
- Revenue Next Year
- ACET N/A
- FSHP N/A
- P/E Ratio
- ACET N/A
- FSHP $89.55
- Revenue Growth
- ACET N/A
- FSHP N/A
- 52 Week Low
- ACET $0.81
- FSHP $9.99
- 52 Week High
- ACET $3.62
- FSHP $10.20
- Technical
- Relative Strength Index (RSI)
- ACET 43.86
- FSHP N/A
- Support Level
- ACET $0.85
- FSHP N/A
- Resistance Level
- ACET $0.94
- FSHP N/A
- Average True Range (ATR)
- ACET 0.08
- FSHP 0.00
- MACD
- ACET 0.00
- FSHP 0.00
- Stochastic Oscillator
- ACET 22.16
- FSHP 0.00
About ACET Adicet Bio Inc.
Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Its lead product candidate, ADI-001, a first-in-class allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, is being developed for the potential treatment of autoimmune diseases and relapsed or refractory aggressive B cell non-Hodgkin's lymphoma. Their pipeline also includes its lead preclinical candidate, ADI-270, an armored gamma delta CAR T cell product candidate targeting renal cell carcinoma, with potential for other CD70+ solid tumor and hematological malignancies indications.
About FSHP FLAG SHIP ACQUISITION CORPORATION
Flag Ship Acquisition Corp is a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.